Drug error that harmed Quaid twins shows need for better safety measures
Cedars-Sinai Medical Center takes steps to prevent the heparin drug error, which befell Dennis Quaid's twins.
Patient safety is focus of technology showcase at ASHP meeting
From pharmacy automation to environmentally friendly drug disposal solutions, many new technology products are on display at the ASHP show.
This new service helps you recover lost supply chain dollars
Novation is offering a new service to help member hospitals recover their supply chain dollars.
How to get more out of the 340B drug discount program
Speakers at the AMCP meeting give suggestions on how more hospitals can make use of the 340B program.
How will revised USP 797 guidelines affect you?
The revision emphasizes training and competency of pharmacists.
Letters: January 28, 2008
Drug samples should be replaced by vouchers to reduce drug diversion; chemistry courses are critical to the education of pharmacy students.
Viewpoint: Multiple Schedule II Rxs: Road to disaster?
DEA's new rule allowing multiple prescriptions for Schedule II controlled substances could engender greater Rx drug abuse.
FDA Safety Page: Fatal medication errors with heparin
The risk for fatal medication errors is highlighted in an important new warning within a revised produt label for Heparin Sodium Injection.
Hypertension: So many treatments, yet so undermanaged
Combo drugs are driving drug development in hypertension these days.
Regional Coalitions forming to improve preceptor training
Regional groups are forming to set up standards for experiential training of students.
Clinical Q & A: Can lactose-intolerant patients use lactose-containing medications?
Does the lactose content of medications pose a problem in patients who are lactose intolerant?
Hy-Vee partnering with The Caregivers Marketplace for cash-back program
Hy-Vee joins The Caregivers Marketplace as official retail outlets
Diabetes called a growing public health crisis
Diabetes is taking a greater toll
Miami defendants in strike force case sentenced for Medicare fraud
Nine Miami defendants in strike force cases sentenced for Medicare fraud
Leukine withdrawn from market due to EDTA-related adverse events
Sargramostim withdrawn from market
Free NCPA Respiratory Care Certificate Program launched
NCPA offers free respiratory care certificate program
FDA official: Biomarkers can change the future
Biomarkers may be on the verge of changing medicine, but they need a push.
Reducing your risk: Medication errors – The value of habit
A safe workflow that's ingrained in pharmacists can do much to reduce the likelihood of drug errors.
CVS launches monthly magazine for purchasers of healthcare products
CVS/Pharmacy sponsors magazine for top-tier healthcare purchasers
OTC allergy drugmakers are ready to battle for consumers
OTC allergy drug battle heats up
Once-daily amoxicillin approved
Moxatag is the name of a new once-daily amoxicillin product for pharyngitis and tonsillitis following strep throat
Few people are taking advantage of immunizations
New CDC data show that while there are 17 diseases against which the public can be immunized, adoption rates are low
Antihistamine's new label covers both indoor and outdoor allergies
In a new labeling change, Schering-Plough's Claritin can now treat both indoor and outdoor allergies
Another health plan picks Outcomes group for MTM
Outcomes Pharmaceutical Care has been chosen by Senior Whole Health to provide medication therapy management to its drug plan
Heparin injection recalled as Baxter investigates
Baxter issues voluntary recall of heparin
Illinois college of pharmacy temporarily closed due to fire
Fire temporarily closes UIC College of Pharmacy
Standstill period on Teva's launch of generic pantoprazole extended
Wyeth, Teva extend standstill period on Teva's launch of generic pantoprazole
Study: Women's use of supplements is down
Women's supplement usage declining
Direct renin inhibitor/diuretic combo gets FDA nod
Aliskiren and hydrochlorothiazide combination approved
New HIV drug approved on accelerated basis
Tibotec's Intelence is approved for use with other antiretrovirals to treat HIV
